Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system?

Keyphrases

• Nervous System 100%
• Direct Action 100%
• N-3 Polyunsaturated Fatty Acids 100%
• Pathological Pain 100%
• Eicosanoid Metabolism 40%
• Major Depressive Disorder 20%
• Protein Kinase 20%
• Multiple Sclerosis 20%
• Developed Countries 20%
• Ventricular Arrhythmia 20%
• Rheumatoid Arthritis 20%
• Neuropathic Pain 20%
• Gene Expression 20%
• Pain Conditions 20%
• Protective Effect 20%
• Inflammatory Bowel Disease 20%
• Autoimmune Disease 20%
• Inflammatory Diseases 20%
• Voltage-gated Sodium Channel 20%
• Glial Cells 20%
• Neural Effects 20%
• Neuronal Proteins 20%
• Peripheral Tissues 20%
• Neuronal Processes 20%
• Cytokine Production 20%
• Modifying Effect 20%
• Non-neural 20%
• Sympatholytics 20%
• Glial Process 20%
• Inflammatory Pain 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Omega-3 Fatty Acid 100%
• Icosanoid 40%
• Protein Kinases 20%
• Rheumatoid Arthritis 20%
• Neuropathic Pain 20%
• Autoimmune Disease 20%
• Major Depression 20%
• Inflammatory Disease 20%
• Inflammatory Bowel Disease 20%
• Cytokine 20%
• Atherosclerosis 20%
• Multiple Sclerosis 20%
• Voltage Gated Sodium Channel 20%
• Adrenergic Receptor Blocking Agent 20%
• Inflammatory Pain 20%
• Heart Ventricle Arrhythmia 20%
• Inflammatory Arthritis 20%